Data investigation
Is the Vial You Received What the Label Says?
FDA has found labels naming compounding pharmacies that do not exist, and labels naming real pharmacies that did not make the product. What to check when the box arrives, and what the 990 adverse event reports mean.
Most advice about buying medication online stops at the moment you pay. This picks up after that, because the FDA’s published concerns are overwhelmingly about what turns up in the box. They include labels that name compounding pharmacies which do not exist, and labels naming real pharmacies that had nothing to do with the product inside.[1] If your check was “the label names a pharmacy”, that check does not work.
The label is not evidence of who made it
The FDA has described fraudulent compounded semaglutide and tirzepatide sold in the United States carrying false information on the label. It describes two patterns: pharmacies named on the label that the agency could not find because they are not real, and the names of genuine licensed pharmacies printed on products those pharmacies did not compound.[1]
The second is the more unsettling of the two, because it defeats the obvious verification. You look up the pharmacy, it exists, it holds a real state license, everything checks out, and none of that says anything about the vial in your hand. The agency has one adverse event report tied to a product labeled as compounded tirzepatide from a pharmacy that did not compound it, with redness, swelling, pain and a lump at the injection site.[1]
FDA has found the names of genuine licensed pharmacies printed on products those pharmacies did not compound.
The check that does work is to go the other way: contact the pharmacy or the telehealth company directly and ask them to confirm this order, this lot. FDA’s own guidance points patients to the compounder or the platform they bought from for exactly this kind of question.[1] If a seller cannot connect a lot number to a named pharmacy, treat that as a warning. Collective, which sells compounded semaglutide and tirzepatide, describes its suppliers on its site only as regulated US pharmacy partners, so that question goes to the company itself.
That call is simpler when you already know whom to ask, so note which pharmacy your seller says it uses before the box arrives. Some name a single one. EdgeRx names Strive Pharmacy, CeliaRx says it works only with Partell Pharmacy, and OurView Health names Boudreaux’s New Drug Store in Louisiana. Docberry names Olympia Pharmaceuticals, Mixx Health & Wellness names Promise Pharmacy, and JumpstartMD names PerfectRx for its compounded options.
Nex Gen Health Rx gives one footer address for both itself and Manifest Pharmacy in Greer, South Carolina, and CLYR Health names The Pharmacy Hub in Miami as the pharmacy that fills its vials. NuviaRx lists two pharmacies that may fill an order, Manifest Pharmacy and RX Compounding Store, so with a seller like that the label tells you which of the two to call, and the call tells you whether it was them. Direct Meds also names two, CraftedRx in Missouri and ChemistryRx in Pennsylvania, and says which states each one fills.
Counterfeits of the brand product too
This is not only a compounding story. The FDA has said it is aware of counterfeit Ozempic marketed in the United States. Counterfeits claim to be authentic while potentially containing the wrong ingredients, too little or too much active ingredient, none at all, or something harmful.[1]
Buying the brand does not by itself remove this risk; buying the brand from a state-licensed pharmacy is what does. Our verification guide covers how to establish that a pharmacy is what it claims to be.
If it arrives warm, the answer is no
Injectable GLP-1 drugs need refrigeration, and their package inserts say so. The FDA has received complaints about compounded GLP-1s arriving warm, or with too little ice to have kept them cold in transit, and its recommendation is not to use a product that arrives that way.[1] Sellers rarely tell you in advance how they prevent it: in our register, 192 advertise free or included shipping, and 29 say anything about keeping it cold.
- Open the box the day it lands, not the evening you plan to inject. If it sat on a doorstep all afternoon, the warming has already happened, and opening it later only delays finding out.
- Photograph the ice pack and the box before you unpack. If you need to ask for a replacement, that photograph is your evidence.
- Melted or missing ice is what counts, however the vial looks, because degraded product looks completely normal.
- Do not put it in the fridge and use it anyway. Chilling something afterward does not undo the excursion.
The dosing errors are their own category
The FDA has received multiple reports of adverse events, some requiring hospitalization, that may relate to dosing errors with compounded injectable semaglutide. These came from patients measuring and self-administering the wrong amount, and in some cases from clinicians miscalculating the dose.[1]
Vials make this error easy in a way pens do not. A pen meters the dose; a vial and syringe ask you to produce it, from a concentration the pharmacy chose. Our unit converter does that arithmetic, but the safest approach is to have the prescriber write the dose in units for the exact concentration you were sent.
Separately, the agency has had reports involving doses beyond what the approved labeling describes: more product per dose, doses taken more often, or titration climbing faster than the label schedule.[1] If a plan you have been given moves faster than the label, ask about it before the next injection.
What the adverse event counts do and do not tell you
As of May 31, 2026, the FDA had received 990 reports of adverse events associated with compounded semaglutide and more than 730 associated with compounded tirzepatide.[1] Those numbers are quoted often, and almost always wrongly.
They are not rates. Nobody knows how many people took compounded GLP-1s over the same period, so there is no denominator and no percentage can be built from them. And they are floors rather than totals, because federal law does not require state-licensed pharmacies that are not outsourcing facilities to report adverse events to the FDA at all. The agency says that events from compounded versions are likely underreported.[1]
If something happens to you, the reporting route is MedWatch, and it takes a few minutes.[1] Given that pharmacies in this category are not obliged to report, a patient report may be the only way a given problem is ever counted.
Frequently Asked Questions
References
- 1.U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — drug alert, content current as of October 1, 2026 FDA. 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
Compare the sellers
Seller reviews
Related research
What Cannot Legally Be Compounded, and Who Is Selling It Anyway
Federal law bars retatrutide and cagrilintide from compounding entirely. We checked our own 560-seller register against that rule, found 7 with it on the menu, and discovered our own reviews were not telling readers.
8 min read
BPC-157 FDA Status: What the Agency Put on the Record
Not approved, and not on the list of substances a 503A compounding pharmacy may use. FDA recorded specific concerns: immunogenicity, peptide impurities, and “no, or only limited, safety-related information”.
8 min read
CJC-1295 and Ipamorelin: What FDA Recorded
Sold as a stack for fat loss. FDA identified serious adverse events with CJC-1295 (increased heart rate and systemic vasodilatory reaction), and neither peptide has a weight-loss trial.
7 min read
What Makes a Telehealth GLP-1 Prescription Legitimate
The FDA publishes seven warning signs for telehealth medicine sellers. Here they are, with what proper prescribing looks like and the one disclosure that 139 of our 560 sellers failed in an August 2026 count.
7 min read
What the FDA's GLP-1 Warning Letters Say About This Market
Two letters in 2023, ten in 2024, 72 in 2025. The most common subject is unlawful sale to consumers: enforcement here is overwhelmingly about what sellers said, not what pharmacies made.
6 min read
HCG, B12 and Lipotropic Shots: What the Labels and the FDA Say
HCG's own FDA-approved labeling states there is no substantial evidence it increases weight loss beyond caloric restriction. The 500-calorie diet it is sold with is the part that works, and the part that is dangerous.
6 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Embody
A flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
From $79/mo
Get started →Bodybuilding Health+
Seeing what it charges before you answer any medical questions
From $179/mo
Get started →YourEra
Semaglutide at $99/month, well below the typical price
From $99/mo
Get started →